1
NR 565 Week 7 GI Case Study (Original
Post with Responses)
Original Post
1. What are your treatment goals for Mr. Brown today?
The immediate goal of the treatment is to relieve Mr. Brown of stomach pain. According to the
presented symptoms, the suspected diagnosis would be peptic ulcers. Therefore, the goal of the
treatment in the relief of pain should include relieving the symptoms, healing lesions, and
preventing recurrences and complications.
2. What is your pharmacological plan and rationale?
The management of a patient with gastrointestinal (GI) haemorrhage is different from the initial
management of a stable patient with dyspepsia. In the former scenario, the failure of medical
management does not commonly imply the need for surgical intervention. The available
treatment options include empiric triple therapy of H Pylori infection, empiric antisecretory
therapy, an endoscopy that informs treatment course based on the findings, and a triple therapy
after an H Pylori serology for infected patients. Additionally, breath testing could be used for
active H Pylori infection. According to the 2017 American College of Gastroenterology (ACG)
guidelines for the treatment of H Pylori infection, a 10-14 days of quadruple therapy with proton
pump inhibitor (PPI), bismuth, nitroimidazole, and tetracycline is recommended (Chey et al.,
2017). Alternatively, a 10-14 days of clarithromycin, concomitant PPI, nitroimidazole, and
amoxicillin could be used for the management.
The quadruple management of H Pylori includes the following drugs and should be
administered for 14 days;
This study source was downloaded by 100000847795904 from CourseHero.com on 06-01-2022 05:11:52 GMT -05:00
https://www.coursehero.com/file/78741947/NR565-Week-7-GI-Case-Studydocx/
NR 565 Week 7 GI Case Study (Original
Post with Responses)
Original Post
1. What are your treatment goals for Mr. Brown today?
The immediate goal of the treatment is to relieve Mr. Brown of stomach pain. According to the
presented symptoms, the suspected diagnosis would be peptic ulcers. Therefore, the goal of the
treatment in the relief of pain should include relieving the symptoms, healing lesions, and
preventing recurrences and complications.
2. What is your pharmacological plan and rationale?
The management of a patient with gastrointestinal (GI) haemorrhage is different from the initial
management of a stable patient with dyspepsia. In the former scenario, the failure of medical
management does not commonly imply the need for surgical intervention. The available
treatment options include empiric triple therapy of H Pylori infection, empiric antisecretory
therapy, an endoscopy that informs treatment course based on the findings, and a triple therapy
after an H Pylori serology for infected patients. Additionally, breath testing could be used for
active H Pylori infection. According to the 2017 American College of Gastroenterology (ACG)
guidelines for the treatment of H Pylori infection, a 10-14 days of quadruple therapy with proton
pump inhibitor (PPI), bismuth, nitroimidazole, and tetracycline is recommended (Chey et al.,
2017). Alternatively, a 10-14 days of clarithromycin, concomitant PPI, nitroimidazole, and
amoxicillin could be used for the management.
The quadruple management of H Pylori includes the following drugs and should be
administered for 14 days;
This study source was downloaded by 100000847795904 from CourseHero.com on 06-01-2022 05:11:52 GMT -05:00
https://www.coursehero.com/file/78741947/NR565-Week-7-GI-Case-Studydocx/
